Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Amortization - Intangibles (2020 - 2025)

Haemonetics has reported Amortization - Intangibles over the past 6 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $10.9 million for Q4 2025, down 10.61% from a year ago — trailing twelve months through Dec 2025 was $44.8 million (down 5.46% YoY), and the annual figure for FY2025 was $48.3 million, up 50.67%.
  • Amortization - Intangibles for Q4 2025 was $10.9 million at Haemonetics, down from $11.2 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for HAE hit a ceiling of $12.5 million in Q2 2024 and a floor of $6.9 million in Q4 2023.
  • Median Amortization - Intangibles over the past 5 years was $11.1 million (2025), compared with a mean of $10.1 million.
  • Biggest five-year swings in Amortization - Intangibles: plummeted 33.52% in 2022 and later surged 76.96% in 2024.
  • Haemonetics' Amortization - Intangibles stood at $11.4 million in 2021, then dropped by 29.14% to $8.1 million in 2022, then decreased by 14.45% to $6.9 million in 2023, then surged by 76.96% to $12.2 million in 2024, then fell by 10.61% to $10.9 million in 2025.
  • The last three reported values for Amortization - Intangibles were $10.9 million (Q4 2025), $11.2 million (Q3 2025), and $11.4 million (Q2 2025) per Business Quant data.